Masashi Kurimoto

This inventor holds 66 USPTO granted patents and 1 published patent application, plus 1 CIPO patent, primarily in Interferon Production (CPC class 5303). Top assignees: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Sansho Seiyaku Kabushiki Kaisha, Hayashibara Co., Ltd.. Active years: 1977-2014.

USPTO Granted Patents = 66 (Patent Applications = 1)

% Patents Active = 83.3

CIPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.3

ph-index = 10

Forward Citations = 373(Granted Patents)

Forward Citations (Not Self Cited) = 349(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Okayama, JA (1977)
Okayamai, JP (2010)
Okayama, JP (1988 - 2014)

Company Filing History:

61 out of 375

Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo

patents

3 out of 2

Sansho Seiyaku Kabushiki Kaisha

patents

2 out of 47

Hayashibara Co., Ltd.

patents

4. 1 out of 1

Kaisha Hayashibara Seibutsu Kagaku Kenkyujo

patent

5. 1 out of 5

Seibutsu Kagaku Kenkyujo

patents

6. 4 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1977-2014

Loading Chart...

Areas of Expertise:

Interferon-Gamma

Monoclonal Antibody

Pharmaceutical Composition

Polypeptide

Interleukin-18

Calcium Tissue Strengthening

L-Asparaginase

Osteoporosis Treatment

DNA Encoding

Protein Synthesis

Immunocompetent Cells

Therapeutic Agents

66 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8778882 - Agent for strengthening calcium containing tissue and use thereof (2014-07-15),

2. 7758853 - IFN-γ production inducing protein (IGIF, IL-18) (2010-07-20),

3. 7732425 - Pharmaceutical composition for ophthalmic use (2010-06-08),

4. 7666403 - Mutant interferon α protein and use thereof (2010-02-23),

5. 7405048 - Method for detecting a polypeptide which induces interferon-γ production (2008-07-29),

6. 7355014 - Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use (2008-04-08),

7. 7230079 - Antiallergic agent (2007-06-12),

8. 7189389 - Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes (2007-03-13),

9. 7141393 - Interleukin-18-receptor proteins (2006-11-28),

10. 7135458 - Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use (2006-11-14),

11. 7037685 - DNA encoding loypeptides having interferon-γ inducing activity (2006-05-02),

12. 6896880 - Method for treating a disease associated with excessive osteoclast formation (2005-05-24),

13. 6790442 - Genomic DNA encoding a polypeptide capable of inducing the production of interferon-&ggr; (2004-09-14),

14. 6773701 - Expression enhancer for protein synthesis inhibitory genes (2004-08-10),

15. 6713618 - DNA which encodes trehalase and uses thereof (2004-03-30),

Sure, I can certainly help you with that! Here is the article about inventor Masashi Kurimoto:

Title: The Pioneering Legacy of Masashi Kurimoto in Innovation

Introduction:

In the world of innovation, Masashi Kurimoto stands as a beacon of inspiration and dedication, known for pushing the boundaries of what is possible. His relentless pursuit of groundbreaking solutions continues to shape future generations of inventors and innovators worldwide.

Latest Patents:

Masashi Kurimoto's extensive portfolio boasts 66 patents, showcasing his commitment to developing novel solutions. Among his latest patents are:

1. Agent for strengthening calcium-containing tissue and its use: An innovative agent comprising various compounds to enhance calcium-containing tissues safely.

2. IFN-γ production-inducing protein (IGIF, IL-18): A protein isolated from mouse liver that stimulates IFN-γ production in immunocompetent cells, offering significant potential in the field of immunology.

Career Highlights:

Throughout his illustrious career, Masashi Kurimoto has made significant contributions to companies such as Hayashibara Seibutsu Kagaku Kenkyujo, leaving a lasting impact on various industries. His dedication to innovation and problem-solving has led to the development of groundbreaking solutions that have revolutionized the way we approach scientific challenges.

Collaborations:

Masashi Kurimoto has collaborated with esteemed colleagues such as Kakuji Torigoe and Keizo Kohno, demonstrating his ability to work effectively in multidisciplinary teams. These collaborations have not only enhanced the quality of his work but have also fostered a culture of innovation and knowledge-sharing.

Conclusion:

In conclusion, Masashi Kurimoto's pioneering spirit and unwavering dedication to innovation have left an indelible mark on the world of science and technology. His legacy serves as a testament to the transformative power of human ingenuity, inspiring generations of inventors and innovators to push the boundaries of what is possible.